• USA Home
  • SRP4497 - Eotaxin-2/CCL24 human

EMAIL THIS PAGE TO A FRIEND
SRP4497 Sigma-Aldrich

Eotaxin-2/CCL24 human

recombinant, expressed in E. coli, ≥97% (SDS-PAGE)

Synonym: C-C motif chemokine 24, CK-β-6, Eosinophil chemotactic protein 2, Eotaxin-2, Myeloid progenitor inhibitory factor 2, Small-inducible cytokine A24

Purchase

Properties

Related Categories Cell Biology, Cell Signaling and Neuroscience, Chemokines, Cytokines and Growth Factors, Cytokines, Growth Factors and Chemokines for Stem Cell Differentiation,
biological source   human
recombinant   expressed in E. coli
assay   ≥97% (SDS-PAGE)
form   lyophilized
potency   10 ng/mL
mol wt   ~8.8 kDa
packaging   pkg of 20 μg
storage condition   avoid repeated freeze/thaw cycles
impurities   endotoxin, tested
NCBI accession no.   O00175
UniProt accession no.   O00175
shipped in   wet ice
storage temp.   −20°C
Gene Information   human ... CCL24(6369)

Description

General description

Eotaxin-2 also known as MPIF-2 is a CC chemokine characterized by its high chemotactic selectivity for eosinophils. Human eotaxin-2 is 8.8 kDa protein containing 78 amino acid residues.

Physical form

The protein was lyophilized from a concentrated (1 mg/ml) sterile solution containing 20 mM PBS pH-7.4 and 0.15 M sodium chloride.

Reconstitution

Centrifuge the vial prior to opening. Avoid freeze-thaw cycles.

Reconstitute in water to a concentration of 0.1-1 μg/μL. It is recommended that further dilutions be made into buffer containing carrier protein or medium containing serum.

Safety & Documentation

Safety Information

WGK Germany 
3

Documents

Certificate of Analysis

???PDP_SDS_LOT_NUMBER_ERROR_MSG???

Request a Serum Sample

Milli-Q® Water Purification Solutions
Protocols & Articles
Related Products

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?